EGFR and oral cavity squamous cell carcinoma: Overexpression and increased signalling from the epidermal growth factor receptor (EGFR)often change oral squamous cell carcinoma (OSCC) and thus EGFR is frequently targetedmolecularly by the therapeutic antibody cetuximab.